Eli Lilly and Company Stock News
$1,025.28
0.24%
NYSE,
Nov 14, 10:12 pm CET
Index
Industry
Eli Lilly and Company Stock News
Positive
The Motley Fool
●
5 days ago
Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed.
Positive
24/7 Wall Street
●
5 days ago
From late 2020 to the summer of 2024, Eli Lilly & Co. (NYSE: LLY) stock was on a tear, up more than 635%, before taking a breather this year.
Positive
The Motley Fool
●
5 days ago
Eli Lilly released more positive mid-stage clinical trial results for a weight management candidate. The company should dominate this area through the end of the decade, at least, despite the competition.
Negative
Reuters
●
5 days ago
Eli Lilly is dropping CVS Health's drug benefit plan for its employees after CVS stopped covering its weight-loss drug in favor of a rival medication from Novo Nordisk , Bloomberg News reported on Tuesday, citing people familiar with the matter.
Positive
Market Watch
●
6 days ago
Even by dramatically lowering the prices of some of its medications, the drug giant is still outpacing its rivals and nearing a trillion-dollar valuation.
Positive
The Motley Fool
●
6 days ago
New technologies and an aging population are lifting the healthcare sector. Immunotherapy and anti-obesity drugs are leading the way.
Neutral
The Motley Fool
●
6 days ago
Eli Lilly's GLP-1 drug is now the world's best-selling drug. Novo Nordisk is struggling with declining market share.
Neutral
24/7 Wall Street
●
7 days ago
In addition, according to analysts at UBS, it sees Nvidia guiding fourth quarter revenue to a range of $63 billion to $64 billion.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
